dexmedetomidine has been researched along with cytochrome c-t in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Lu, K; Ma, D; Sun, JJ; Wang, C; Zhao, H | 1 |
| Cui, J; Lu, K; Ma, D; Yi, B; Zeng, J; Zhao, H | 1 |
| Du, J; Leng, JY; Liu, J; Xu, Z; Yang, D; Zhen, J; Zheng, EL | 1 |
| Feng, Z; Guo, M; Hu, Q; Ren, B; Tian, Y; Xie, Q; Xu, C; Yu, J; Zhang, W | 1 |
| An, JX; Guo, J; Lu, GF; Niu, K; Qin, JL; Williams, JP | 1 |
| Li, D; Li, J; Li, Q; Liu, W; Qian, J; Wang, J; Wu, D | 1 |
| An, J; Guo, J; Ma, B; Niu, K; Sun, L; Tu, J | 1 |
7 other study(ies) available for dexmedetomidine and cytochrome c-t
| Article | Year |
|---|---|
Dexmedetomidine attenuates oxidative stress induced lung alveolar epithelial cell apoptosis in vitro.
Topics: Apoptosis; bcl-2-Associated X Protein; Cadherins; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cytochromes c; Dexmedetomidine; Down-Regulation; Epithelial Cells; Humans; Hydrogen Peroxide; Imidazoles; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Up-Regulation | 2015 |
Dexmedetomidine Attenuates Bilirubin-Induced Lung Alveolar Epithelial Cell Death In Vitro and In Vivo.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Cell Culture Techniques; Cell Cycle; Cytochromes c; Dexmedetomidine; Edema; Epithelial Cells; Humans; Hyperbilirubinemia; Membrane Potential, Mitochondrial; Prospective Studies; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley | 2015 |
Dexmedetomidine attenuates myocardial ischemia/reperfusion injury through regulating lactate signaling cascade in mice.
Topics: Animals; Caspase 3; Caspase 9; Coronary Vessels; Cytochromes c; Dexmedetomidine; Disease Models, Animal; Humans; Lactic Acid; Male; Mice; Mitochondria; Monocarboxylic Acid Transporters; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Signal Transduction; Symporters | 2019 |
Dexmedetomidine Attenuates Glutamate-Induced Cytotoxicity by Inhibiting the Mitochondrial-Mediated Apoptotic Pathway.
Topics: Animals; Apoptosis; Cell Survival; Cytochromes c; Dexmedetomidine; Glucose; Glutamic Acid; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; PC12 Cells; Protective Agents; Rats; Reactive Oxygen Species; Signal Transduction | 2020 |
Dexmedetomidine Reverses Postoperative Spatial Memory Deficit by Targeting Surf1 and Cytochrome c.
Topics: Animals; Cytochromes c; Dexmedetomidine; Hippocampus; Male; Memory Disorders; Propofol; Rats; Rats, Sprague-Dawley | 2021 |
Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
Topics: Adenosine Monophosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury, Chronic; Cyclooxygenase 2; Cytochromes c; Dexmedetomidine; Glutathione; MAP Kinase Signaling System; MicroRNAs; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2022 |
Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C.
Topics: Animals; Cytochromes c; Dexmedetomidine; Hippocampus; Humans; Male; Memory Disorders; Propofol; Rats; Rats, Sprague-Dawley; Spatial Memory | 2023 |